Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.2K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.2K
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

255
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
255
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

203
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
203
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

217
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
217
Sustainable Development01:43

Sustainable Development

15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative MRI Assessment of Myotoxin-Induced Skeletal Muscle Damage of mdx Mice.

Muscle & nerve·2026
Same author

Dystrophins DP71 and DP427 determine cell viability during proliferation and myofibre differentiation.

Cell death & disease·2026
Same author

Daily associations of three types of social control with physical activity, reactance, and mood in romantic couples: a dyadic intensive longitudinal study.

Psychology & health·2026
Same author

Genetic strategies for therapy of Duchenne muscular dystrophy.

Molecular therapy. Nucleic acids·2025
Same author

Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle.

JCI insight·2025
Same author

The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Related Experiment Video

Updated: Jan 29, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.8K

Development of Novel Micro-dystrophins with Enhanced Functionality.

Julian N Ramos1, Katrin Hollinger2, Niclas E Bengtsson2

  • 1Molecular and Cellular Biology Program, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Neurology, University of Washington School of Medicine, Seattle, WA 98195, USA; Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, Seattle, WA 98195, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|February 6, 2019
PubMed
Summary

Gene therapy for Duchenne muscular dystrophy (DMD) faces challenges with adeno-associated viral (AAV) vector size limits. Researchers developed improved micro-dystrophins (μDys) that enhance muscle function, with one variant advancing to clinical trials.

Keywords:
AAVDMDDuchenne muscular dystrophyclinical trialsdystrophingene therapy

More Related Videos

Utilization of Plasmonic and Photonic Crystal Nanostructures for Enhanced Micro- and Nanoparticle Manipulation
09:29

Utilization of Plasmonic and Photonic Crystal Nanostructures for Enhanced Micro- and Nanoparticle Manipulation

Published on: September 27, 2011

12.7K
Utilization of Stop-flow Micro-tubing Reactors for the Development of Organic Transformations
13:09

Utilization of Stop-flow Micro-tubing Reactors for the Development of Organic Transformations

Published on: January 4, 2018

39.7K

Related Experiment Videos

Last Updated: Jan 29, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.8K
Utilization of Plasmonic and Photonic Crystal Nanostructures for Enhanced Micro- and Nanoparticle Manipulation
09:29

Utilization of Plasmonic and Photonic Crystal Nanostructures for Enhanced Micro- and Nanoparticle Manipulation

Published on: September 27, 2011

12.7K
Utilization of Stop-flow Micro-tubing Reactors for the Development of Organic Transformations
13:09

Utilization of Stop-flow Micro-tubing Reactors for the Development of Organic Transformations

Published on: January 4, 2018

39.7K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Adeno-associated viral (AAV) vectors are used in gene therapy for Duchenne muscular dystrophy (DMD).
  • AAV vectors have limited carrying capacity (approximately 5 kb), posing challenges for delivering large genes like dystrophin (2.2 Mb).
  • Previous micro-dystrophin (μDys) designs showed partial function but require improvement for therapeutic efficacy.

Purpose of the Study:

  • To engineer novel micro-dystrophin (μDys) variants with enhanced functionality for Duchenne muscular dystrophy (DMD) gene therapy.
  • To investigate the impact of structural modifications in the dystrophin central rod domain on protein performance.
  • To evaluate the efficacy of engineered μDys variants delivered via AAV vectors in a mouse model of DMD.

Main Methods:

  • Designed and constructed eight μDys variants with varying spectrin-like repeats and hinge domains.
  • Utilized AAV vectors with muscle-restricted (CK8e) or ubiquitous (CMV) regulatory cassettes for μDys expression.
  • Administered vectors via intramuscular injection and systemic delivery to dystrophic mdx4cv mice.
  • Assessed skeletal muscle pathophysiology, including force generation and sarcolemmal localization of neuronal nitric oxide synthase.

Main Results:

  • Identified two μDys designs that significantly improved force generation compared to previous variants.
  • Demonstrated successful localization of neuronal nitric oxide synthase to the sarcolemma with the improved μDys.
  • One optimized variant, μDys5, delivered via AAV with the CK8e regulatory cassette, showed promising results.

Conclusions:

  • Structural modifications of the dystrophin central rod domain can yield μDys variants with superior functional outcomes.
  • Engineered μDys proteins hold potential for improving skeletal muscle function in Duchenne muscular dystrophy (DMD).
  • The μDys5 variant is a promising candidate for AAV-mediated gene therapy and is currently under clinical evaluation for DMD.